For today’s episode we’re joined by Cosmo Feilding Mellen, CEO of Beckley Psytech. 

Born out of the Beckley Foundation – a world-renowned organisation who have been central to drug policy reform and research into psychoactive substances for over two decades – Cosmo and his team are at the forefront of modern-day psychedelic science. 

With clinical trials currently in play and a bulging war chest following an oversubscribed Series B funding round, tune in to hear what’s being cooked up at Beckley HQ and more.

Take a look at the full collection of podcasts and explore additional cannabis & psychedelics content on the GCI Content Hub: https://contenthub.gcintelligence.com/